BBVA
NGNE icon

Banco Bilbao Vizcaya Argentaria’s Neurogene NGNE Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-750
Closed -$170K – 780
2020
Q1 		$170K Hold
750
– – 0.01% 634
2019
Q4 		$182K Buy
+750
New +$74.7K 0.01% 685

Other funds holding NGNE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's NGNE Position: Q2 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Neurogene (NGNE) in Q2 2020, closing a stake of 750 shares — an estimated $170K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in NGNE in Q4 2019 and held it in 2 quarters. The position peaked at $182K in Q4 2019. 74 funds tracked by Wall St. Rank hold NGNE as of Q2 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Neurogene position as of Q2 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 750 Neurogene shares in Q2 2020, an estimated $170K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Neurogene in Q4 2019 and held it in 2 quarters.
  • Banco Bilbao Vizcaya Argentaria's Neurogene position peaked at $182K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Neurogene as of Q2 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q2 2020, filed 12 Aug 2020.